PSILOCYBIN
Dec 01, 2019
2 minutes
In 2016, the Beckley/Imperial Research Programme released a study that revealed the staggering potential of psilocybin to alleviate treatment-resistant depression, with 67 percent of participants being depression-free after one week, and 42 percent remaining in remission three months later. Using the latest brain-imaging techniques, the Beckley Foundation has shed some light on how
You’re reading a preview, subscribe to read more.
Start your free 30 days